Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C McArthur

Showing results (351-360 of 359) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 359 results.
Journal of Neurovirology|October 18, 2012
Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTEREmily R Holzinger, Todd Hulgan, Ronald J Ellis, et al.
Neurology|October 5, 2007
Updated research nosology for HIV-associated neurocognitive disordersA Antinori, G Arendt, J T Becker, et al.
Journal of Neurovirology|February 15, 2013
Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disordersE E Morgan, S P Woods, S L Letendre, et al.
Neurology|May 13, 2014
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic declineIgor Grant, Donald R Franklin, Reena Deutsch, et al.
Journal of Neurovirology|May 6, 2011
Clinical factors related to brain structure in HIV: the CHARTER studyTerry L Jernigan, Sarah L Archibald, Christine Fennema-Notestine, et al.
Journal of Neurovirology|July 11, 2013
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infectionChristine Fennema-Notestine, Ronald J Ellis, Sarah L Archibald, et al.
Neurology|December 8, 2010
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyR K Heaton, D B Clifford, D R Franklin, et al.
Journal of Neurovirology|December 22, 2010
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsRobert K Heaton, Donald R Franklin, Ronald J Ellis, et al.
The Journal of Pain|March 4, 2017
The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT ConsiderationsShannon M Smith, Robert H Dworkin, Dennis C Turk, et al.
Pageof 36

Showing results (351-360 of 359) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 359 results.
Journal of Neurovirology|October 18, 2012
Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTEREmily R Holzinger, Todd Hulgan, Ronald J Ellis, et al.
Neurology|October 5, 2007
Updated research nosology for HIV-associated neurocognitive disordersA Antinori, G Arendt, J T Becker, et al.
Journal of Neurovirology|February 15, 2013
Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disordersE E Morgan, S P Woods, S L Letendre, et al.
Neurology|May 13, 2014
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic declineIgor Grant, Donald R Franklin, Reena Deutsch, et al.
Journal of Neurovirology|May 6, 2011
Clinical factors related to brain structure in HIV: the CHARTER studyTerry L Jernigan, Sarah L Archibald, Christine Fennema-Notestine, et al.
Journal of Neurovirology|July 11, 2013
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infectionChristine Fennema-Notestine, Ronald J Ellis, Sarah L Archibald, et al.
Neurology|December 8, 2010
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyR K Heaton, D B Clifford, D R Franklin, et al.
Journal of Neurovirology|December 22, 2010
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsRobert K Heaton, Donald R Franklin, Ronald J Ellis, et al.
The Journal of Pain|March 4, 2017
The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT ConsiderationsShannon M Smith, Robert H Dworkin, Dennis C Turk, et al.
Pageof 36